Loading
Loading
Research Overview
Khavinson tripeptide bioregulator (Glu-Asp-Arg) targeting the cerebral cortex; proposed to modulate gene expression governing neuronal repair, neuroplasticity, and melatonin/serotonin balance in the pineal region.
Pinealon is an ultrashort regulatory peptide composed of three amino acids—glutamic acid, aspartic acid, and arginine (Glu–Asp–Arg)—that has been investigated in preclinical research examining cellular stress regulation in neural systems. It has been studied primarily in in vitro and animal models relevant to oxidative stress, hypoxia, and age-associated neuronal changes, where cellular vulnerability and stress-response signaling are key areas of investigation.
Across these experimental models, Pinealon exposure has been reported to coincide with changes in biochemical and molecular markers associated with oxidative balance, mitochondrial function, and neuronal viability. Studies conducted in neural cell cultures and animal systems have described alterations in antioxidant enzyme activity, lipid peroxidation indicators, mitochondrial-related markers, and stress-response signaling pathways following peptide exposure. These findings are reported within controlled laboratory settings and are interpreted as changes in cellular stress-related processes under experimental conditions.
Mechanistic investigations suggest that ultrashort peptides such as Pinealon may participate in intracellular regulatory processes related to transcriptional activity and stress-response signaling. Proposed mechanisms include indirect modulation of gene expression and regulatory pathways involved in cellular adaptation to metabolic or oxidative stress. While direct interaction between Pinealon and DNA or chromatin structures has not been conclusively demonstrated, reported transcriptional changes support continued investigation of regulatory mechanisms in preclinical systems.
All available data regarding Pinealon originate from preclinical research, including in vitro experiments and animal models. Pinealon is not approved for human use, and no clinical trials have evaluated its safety, pharmacokinetics, or biological effects in humans. Current research positions Pinealon as an investigational peptide used to study cellular stress regulation and regulatory signaling processes in experimental neural models.
Sold strictly as a research chemical for non-human, in-vitro, and laboratory use
FDA approved compound
Prescription availability in Australia and internationally
In Australia, pinealon has no TGA approval for therapeutic use. It is sold by Capital Peptides strictly as a research chemical for non-human, in-vitro, and laboratory research use only.
Pinealon research is most relevant to protocols examining:
Pineal gland and neuroendocrine biology research
Sleep architecture and melatonin/serotonin regulation studies
Neuroplasticity and cognitive decline prevention investigations
Researchers comparing Khavinson bioregulator effects on the CNS
Initial phase
Compound begins accumulating in target tissue. Most researchers note subtle changes by end of week one. Baseline measurements recommended.
Early response
Downstream biological effects become detectable. Key biomarkers worth monitoring from this point.
Peak activity window
Effects compound in this window. Given limited human data, careful documentation is important.
Washout & review
Allow full washout (~5× half-life: ~Hours). Review data, confirm baseline recovery before any repeat protocol.
Khavinson tripeptide bioregulator (Glu-Asp-Arg) targeting the cerebral cortex; proposed to modulate gene expression governing neuronal repair, neuroplasticity, and melatonin/serotonin balance in the pineal region.
| Parameter | Value |
|---|---|
| Dose range | 5–10 mg/day (cycled) |
| Schedule | Daily (cycled) |
| Route | Subcutaneous, Intranasal |
| Half-life | ~Hours |
Available from Capital Peptides
References
For research use only. Capital Peptides products are not approved by the TGA for therapeutic use. By purchasing you confirm you are a licensed research entity or qualified professional.
